home / stock / adxs / adxs news


ADXS News and Press, Advaxis From 11/06/23

Stock Information

Company Name: Advaxis
Stock Symbol: ADXS
Market: NASDAQ
Website: advaxis.com

Menu

ADXS ADXS Quote ADXS Short ADXS News ADXS Articles ADXS Message Board
Get ADXS Alerts

News, Short Squeeze, Breakout and More Instantly...

ADXS - Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors

REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to AL102, a Gamma Secretase Inhibi...

ADXS - Expected US Company Earnings on Monday, November 6th, 2023

CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...

ADXS - Expected US Company Earnings on Monday, October 30th, 2023

FMC Corporation (FMC) is expected to report $0.45 for Q3 2023 NCS Multistage Holdings Inc. (NCSM) is expected to report $2.59 for Q3 2023 Third Century Bancorp (TDCB) is expected to report for Q3 2023 ZoomInfo Technologies Inc. (ZI) is expected to report $0.15 for Q3 2023 Matson I...

ADXS - Expected US Company Earnings on Monday, October 23rd, 2023

Grandsouth Bancorporation (GRRB) is expected to report for quarter end 2023-09-30 Cadence Bank (CADE) is expected to report $0.56 for Q3 2023 Enterprise Financial Services Corporation (EFSC) is expected to report $1.24 for Q3 2023 Blackhawk Bancorp Inc. (BHWB) is expected to report fo...

ADXS - Ayala Pharmaceuticals Presents Updated AL102 Results from Phase 2 Clinical Trial in Desmoid Tumors at ESMO Congress 2023

AL102 1.2 mg once daily treatment achieved Overall Response Rate of 83% in the evaluable population AL102 1.2 mg once daily treatment resulted in 88% reduction in tumor volume and 85% reduction in T2W signal intensity REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Oct. 23, 2023 (GLOBE NEWSW...

ADXS - Ayala Pharmaceuticals Announces Closing of Merger with Biosight

REHOVOT, Israel & MONMOUTH JUNCTION, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the closing of its merger with Biosight, Ltd. (“Biosight”), pursuant to which Ayala acquired Biosight. The c...

ADXS - Expected US Company Earnings on Monday, October 16th, 2023

CrossFirst Bankshares Inc. (CFB) is expected to report $0.33 for Q3 2023 Charles Schwab Corporation (The) (SCHW) is expected to report $0.75 for Q3 2023 Sunwin Stevia International Inc (SUWN) is expected to report for quarter end 2023-07-31 Enerpac Tool Group Corp. (EPAC) is expected ...

ADXS - Expected US Company Earnings on Monday, October 9th, 2023

Environmental Tectonics Corp. (ETCC) is expected to report for Q2 2024 Advaxis Inc. (ADXS) is expected to report for Q3 2023 Sunwin Stevia International Inc (SUWN) is expected to report for quarter end 2023-07-31 Passur Aerospace Inc (PSSR) is expected to report for quarter end 2023-0...

ADXS - Expected US Company Earnings on Monday, October 2nd, 2023

Odyssey Marine Exploration Inc. (OMEX) is expected to report for quarter end 2023-06-30 The Very Good Food Company Inc. (VGFCQ) is expected to report for quarter end 2023-06-30 SeaChange International Inc. (SEAC) is expected to report for Q1 2024 Allena Pharmaceuticals Inc. (ALNAQ) is...

ADXS - Expected US Company Earnings on Monday, September 25th, 2023

QualTek Services Inc. (QTEKQ) is expected to report for Q2 2023 Amerityre Corp (AMTY) is expected to report for quarter end 2023-06-30 BYD Co - Class H (BYDDF) is expected to report for quarter end 2023-06-30 Shionogi & Co. Ltd. ADR (SGIOY) is expected to report for Q1 2024 Ea...

Previous 10 Next 10